Med. Clinic I: Gastroenterology and Hepatology, Pneumology and Allergology, Endocrinology and Diabetology, and Nutritional Medicine -
PD Dr. Dr. Oliver Schröder

>

Expertise

• Diagnostics and therapy of inflammatory bowel diseases and their complications
  
• Epidemiology and health services research
  
• Participation in clinical trials
  
• Target research on primary patient tissue
  
  

>

Resources and Abilities

• Recruitment of patients for clinical trials
  
• Recruitment of primary patient tissues
  
  

>

Staff

• PD Dr. Dr. Oliver Schröder (Group leader)
  
• Dr. Irina Blumenstein
  
• Dr. Johannes Hausmann

>

Publications

• Blumenstein I, Bock H, Weber C, Rambow A, Tacke W, Kihn R, Pfaff R, Orlemann S, Schaeffer R, Schröder O, Dignass A, Hartmann F, Stein J. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: A multicenter, prospective, internet-based study. Inflamm Bowel Dis (2008) 14: 53-60.
  
• Schröder O, Naumann M, Shastri Y, Povse N, Stein J. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther (2007) 26: 1035-42.
  
• Gasché C, Berstad A, Befrits R, Beglinger C, Dignass A, Erichsen K, Gomollon F, Hjortswang H, Koutroubakis I, Kulnigg S, Oldenburg B, Rampton D, Schröder O, Stein J, Travis S, Van Assche G. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 13: 1545-53.
  
• Schröder O, Blumenstein I, Stein J. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. Eur J Gastroenterol Hepatol (2006) 18: 11-16.
  
• Schröder O, Mickisch O, Seidler U, de Weerth A, Dignass AU, Herfarth H, Reinshagen M, Schreiber S, Junge U, Schrott M, Stein J. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease - a randomized, controlled, open-label multicenter study. Am J Gastroenterol (2005) 100: 2503-2509.
  
• Schröder O, Schrott M, Blumenstein I, Jahnel J, Dignass AU, Stein J. A pilot study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal blood loss. Z Gastroenterol (2004) 42: 663-667.
  
• Schröder O, Blumenstein I, Schulte-Bockholt A, Stein J. Combining infliximab and methotrexate in fistulising Crohn's disease resistant or intolerant to azathioprine. Aliment Pharmacol Ther (2004) 19: 295-301.
  
• Schröder O, Naumann M, Stein J. Lack of association between serum anti-Saccharomyces cerevisisae antibodies and therapeutic response to infliximab in patients with refractory Crohn’s disease. Aliment Pharmacol Ther (2004) 20: 823-824.
  
• Schröder O, Stein J. Low dose methotrexate in inflammatory bowel disease – current status and future directions. Am J Gastroenterol (2003) 98: 530-537.
  
• Hirche TO, Russler J, Schröder O, Schuessler G, Kappeser P, Caspary WF, Dietrich CF. The value of routinely performed ultrasonography in patients with Crohn disease. Scand J Gastroenterol (2002)37: 1178-1183.